Patient Management During Major Abdominal Surgery: an Oxygen Consumption Protocol Compared to Standard Approach

NCT ID: NCT03113435

Last Updated: 2025-03-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

76 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-06-01

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study compares the actual standard of care with a new protocol to guide hemodynamic optimization during major abdominal surgery, which is more tailored on patient real needs. During general anesthesia metabolic needs of the body are markedly reduced and increase in CO may not be necessary. In addition, excessive fluid administration has been related to worse post-operative outcomes. We divide patients into three groups: the standard treatment group, the NICE protocol group and the intervention group. In this group we use the v-aCO2/CaO2-CvO2 as marker of tissue ability to increase their oxygen consumption in response to increased O2 delivery, and based on this index the administration of fluid. The principal aim is to optimize functional hemodynamics in order to reduce the fluid balance at the end of the surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hemodynamic Instability

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard

In this group standard care will be provided to patients undergoing major abdominal surgery, regarding hemodynamic optimization

Group Type NO_INTERVENTION

No interventions assigned to this group

NICE group

In this arm patients will be treated according to stroke volume optimization described in NICE program

Group Type ACTIVE_COMPARATOR

Oxygen consumption optimization

Intervention Type OTHER

hemodynamic stability will be achieved through exploration of oxygen consumption need of the patient based on CO2gap/CaO2-CvO2 ratio

Oxygen consumption group

In this arm patients will receive hemodynamic optimization based on their oxygen consumption need

Group Type EXPERIMENTAL

Oxygen consumption optimization

Intervention Type OTHER

hemodynamic stability will be achieved through exploration of oxygen consumption need of the patient based on CO2gap/CaO2-CvO2 ratio

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Oxygen consumption optimization

hemodynamic stability will be achieved through exploration of oxygen consumption need of the patient based on CO2gap/CaO2-CvO2 ratio

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients aged \> 18 years
* acquisition of written informed consent
* Major abdominal surgery (major gastrointestinal surgery: DCP, gastrectomy, Miles, emicolectomy; gynecologic surgery: oncologic surgery) Surgery times ≥ 3 hours

Exclusion Criteria

* Absolute contraindication to CVC placement
* pregnant women
* hepatic surgery
* laparoscopic surgery
* Major vascular surgery
* Dialysis treatment and kidney transplant surgery
* Severe heart failure (EF ≤ 35%)
* Emergency surgery
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Flavia Torrini

UNKNOWN

Sponsor Role collaborator

Alessandra Bisanti

UNKNOWN

Sponsor Role collaborator

Eleonora Filipponi

UNKNOWN

Sponsor Role collaborator

Domenica Luca Grieco

UNKNOWN

Sponsor Role collaborator

Massimo Antonelli

UNKNOWN

Sponsor Role collaborator

Liliana Sollazzi

UNKNOWN

Sponsor Role collaborator

Valter Perilli

UNKNOWN

Sponsor Role collaborator

Andrea Russo

UNKNOWN

Sponsor Role collaborator

Pierpaolo Ciocchetti

UNKNOWN

Sponsor Role collaborator

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Antonio Maria Dell'Anna

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Antonio M Dell'Anna, MD

Role: PRINCIPAL_INVESTIGATOR

Fondazione Policlinico Universitario A. Gemelli

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Fondazione Policlinico A. Gemelli IRCCS

Roma, , Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Antonio M Dell'Anna, MD

Role: CONTACT

+390630154490

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Antonio M Dell'Anna, MD

Role: primary

+390630154490

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1305

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.